LicAGs are amyloid fibrils, indicating their potential significance in AL amyloidosis, especially when monoclonal immunoglobulins are undetectable. They may also serve as indicators of organ involvement and as surrogate markers for treatment response.
Kodama et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: